Jinyu Bio-technology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,241	1,265	1,140	1,712	1,405	1,334
Trading Asset Securities	78.48	120.11	36.83	37.27	46.94	183.85
Cash & Short-Term Investments	1,320	1,385	1,176	1,749	1,452	1,518
Cash Growth	26.11%	17.74%	-32.76%	20.46%	-4.32%	-29.58%
Accounts Receivable	704.1	601.17	648.83	869.84	816.65	742.88
Other Receivables	43.11	63.98	45.14	44.37	57.29	41.49
Receivables	747.2	665.15	693.97	914.21	873.94	904.5
Inventory	259.58	269.13	294.64	322.25	333.46	317.65
Prepaid Expenses	-	0.01	3.49	3.45	-	1.07
Other Current Assets	48.65	24.4	22.93	26.51	20.91	19.4
Total Current Assets	2,375	2,344	2,191	3,016	2,681	2,761
Property, Plant & Equipment	1,842	1,887	1,830	1,892	1,799	1,819
Long-Term Investments	175.07	1,305	1,829	1,025	1,019	1,058
Goodwill	8.2	8.2	8.2	11.41	29.49	94.5
Other Intangible Assets	546.63	572.27	586.76	352.12	347.32	388.45
Long-Term Deferred Tax Assets	126.23	126.54	107.36	96.99	83.43	86.15
Long-Term Deferred Charges	138.57	118.43	69.84	378.12	322.53	260.16
Other Long-Term Assets	1,325	250.28	142.28	100.48	107.87	136.86
Total Assets	6,537	6,612	6,765	6,873	6,389	6,604

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	263.54	256.02	295.84	324.41	354.41	347.05
Accrued Expenses	29.32	73.3	58.85	76.96	101.36	102.82
Short-Term Debt	-	-	15.01	-	10.01	-
Current Portion of Leases	1.05	1.43	1.48	1.53	0.53	0.62
Current Income Taxes Payable	45.45	9.98	4.07	6.92	13.39	7.82
Current Unearned Revenue	89.55	101.45	105.14	98.38	84.65	82.55
Other Current Liabilities	219.4	278.36	244.67	332.25	94.39	148.29
Total Current Liabilities	648.31	720.53	725.06	840.45	658.75	689.15
Long-Term Leases	0.15	0.15	1.25	2.73	0.31	0.16
Long-Term Unearned Revenue	310.55	331.75	345.32	364.84	370.49	343.9
Long-Term Deferred Tax Liabilities	7.87	8.29	9.36	9.63	10.15	10.48
Other Long-Term Liabilities	6	-	268.29	-	-	-
Total Liabilities	972.88	1,061	1,349	1,218	1,040	1,044

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	1,112	1,112	1,120	1,120	1,120	1,126
Additional Paid-In Capital	764.49	751.85	764.9	891.52	834.3	893.34
Retained Earnings	3,881	3,800	3,693	3,673	3,456	3,366
Treasury Stock	-242.3	-242.3	-209.67	-338.48	-338.48	-113.34
Comprehensive Income & Other	-53.16	-53.16	-53.9	20.46	-0.41	-0.23
Total Common Equity	5,461	5,368	5,314	5,367	5,072	5,272
Minority Interest	102.73	182.81	101.04	288.06	277.45	287.98
Shareholders' Equity	5,564	5,551	5,415	5,655	5,350	5,560
Total Liabilities & Equity	6,537	6,612	6,765	6,873	6,389	6,604

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.2	1.58	17.74	4.27	10.85	0.78
Net Cash (Debt)	1,319	1,383	1,159	1,745	1,442	1,517
Net Cash Growth	28.10%	19.41%	-33.61%	21.07%	-4.99%	-29.61%
Net Cash Per Share	1.17	1.24	1.06	1.60	1.30	1.35
Filing Date Shares Outstanding	1,093	1,223	1,117	1,117	1,087	1,103
Total Common Shares Outstanding	1,093	1,223	1,117	1,117	1,087	1,103
Working Capital	1,727	1,623	1,466	2,175	2,022	2,071
Book Value Per Share	5.00	4.39	4.76	4.80	4.66	4.78
Tangible Book Value	4,906	4,788	4,719	5,003	4,695	4,789
Tangible Book Value Per Share	4.49	3.91	4.22	4.48	4.32	4.34
Buildings	-	1,301	1,274	1,153	1,152	1,128
Machinery	-	1,461	1,451	1,354	50.02	1,272
Construction In Progress	-	365.22	201.48	359.22	151.72	128.74